Skip to main content
. 2015 Feb 5;6(10):7584–7596. doi: 10.18632/oncotarget.3170

Table 4. Multivariate analysis of patient survival by combined NDRG4 and p-AKT.

Combined NDRG4/p-AKT Retrospective cohort Prospective cohort
n Unadjusted HR (95% CI) Adjusted HR (95% CI) n Unadjusted HR (95% CI) Adjusted HR (95% CI)
NDRG4 + p-AKT− 70 1.00 (reference) 1.00 (reference) 185 1.00 (reference) 1.00 (reference)
NDRG4 + p-AKT+ 44 1.45 (1.04–3.79) 1.62 (1.08–4.21) 100 1.42 (1.08–2.96) 1.57 (1.09–3.86)
NDRG4 − p-AKT− 68 1.51 (1.04–3.45) 1.76 (1.13–3.43) 148 1.39 (1.09–3.21) 1.62 (1.14–3.58)
NDRG4 − p-AKT+ 90 2.12 (1.14–4.16) 2.43 (1.16–4.26) 275 2.06 (1.11–4.35) 2.29 (1.15–4.18)